litlas
Log inCreate account

Robert S. Negrin

Active 1989–2025

134
Papers
22,425
Citations
85
h-index
131
i10-index

Citations

Citations per year for Robert S. Negrin1948: 1 citations1989: 1 citations1990: 3 citations1991: 2 citations1992: 4 citations1993: 2 citations1994: 5 citations1995: 12 citations1996: 17 citations1997: 19 citations1998: 30 citations1999: 30 citations2000: 50 citations2001: 109 citations2002: 163 citations2003: 169 citations2004: 141 citations2005: 199 citations2006: 222 citations2007: 236 citations2008: 230 citations2009: 215 citations2010: 192 citations2011: 188 citations2012: 201 citations2013: 172 citations2014: 182 citations2015: 144 citations2016: 141 citations2017: 133 citations2018: 117 citations2019: 455 citations2020: 454 citations2021: 546 citations2022: 493 citations2023: 382 citations2024: 593 citations2025: 286 citations2026: 11 citations1949–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,578 citing papers, 35.4% of this breakdownChina: 638 citing papers, 8.8% of this breakdownGermany: 576 citing papers, 7.9% of this breakdownUnited Kingdom: 389 citing papers, 5.4% of this breakdownItaly: 349 citing papers, 4.8% of this breakdownFrance: 311 citing papers, 4.3% of this breakdownCanada: 210 citing papers, 2.9% of this breakdownSpain: 178 citing papers, 2.4% of this breakdownAustralia: 176 citing papers, 2.4% of this breakdownNetherlands: 175 citing papers, 2.4% of this breakdownSwitzerland: 166 citing papers, 2.3% of this breakdownJapan: 162 citing papers, 2.2% of this breakdown
0%35.4%Other 18.8%

Institutions

Fields

  • Medicine58.9%
  • Immunology and Microbiology25.5%
  • Biochemistry, Genetics and Molecular Biology12.8%
  • Engineering1.1%
  • Materials Science0.4%
  • Neuroscience0.4%
  • Other0.9%

Topics

  • Immune Cell Function and Interaction11.8%
  • CAR-T cell therapy research9.3%
  • Hematopoietic Stem Cell Transplantation8.3%
  • T-cell and B-cell Immunology8.2%
  • Immunotherapy and Immune Responses3.8%
  • Virus-based gene therapy research2.6%
  • Other56%

Coauthors

All papers

Open in search
  1. CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

    Authors: Jay Y. Spiegel, Shabnum Patel, Lori Muffly, Nasheed Hossain, Jean Oak, John H. Baird, Matthew J. Frank, Parveen Shiraz, Bita Sahaf, Juliana Craig, María Iglesias, Sheren Younes, Yasodha Natkunam, Michael G. Ozawa, Eric Yang, John Tamaresis, Harshini Chinnasamy, Zachary Ehlinger, Warren D. Reynolds, Rachel C. Lynn, Maria Caterina Rotiroti, Nikolaos Gkitsas, Sally Arai, Laura Johnston, Robert Lowsky, Robbie G. Majzner, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Surbhi Sidana, Judith A. Shizuru, Wen‐Kai Weng, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Magali Bazzano, Jing Zhou, Sean Mackay, Scott J. Bornheimer, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Katherine A. Kong, Nirali N. Shah, Haiying Qin, Terry J. Fry, Steven A. Feldman, Crystal L. Mackall, David B. Miklos - Nature Medicine 2021 cited by 572

  2. Immune reconstitution and infectious complications following axicabtagene ciloleucel therapy for large B-cell lymphoma

    Authors: John H. Baird, David J. Epstein, John Tamaresis, Zachary Ehlinger, Jay Y. Spiegel, Juliana Craig, Gursharan K. Claire, Matthew J. Frank, Lori Muffly, Parveen Shiraz, Everett Meyer, Sally Arai, J. Martin Brown, Laura Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Wen‐Kai Weng, Theresa Latchford, Bita Sahaf, Crystal L. Mackall, David B. Miklos, Surbhi Sidana - Blood Advances 2021 cited by 193

  3. NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects

    Authors: Janelle A. Olson, Dennis B. Leveson-Gower, Saar Gill, Jeanette Baker, Andreas Beilhack, Robert S. Negrin - Blood 2010 cited by 376

  4. CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

    Authors: Matthias Edinger, Petra Hoffmann, Joerg Ermann, Kathryn Drago, C. Garrison Fathman, Samuel Strober, Robert S. Negrin - Nature Medicine 2003 cited by 1,281

  5. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

    Authors: Robert Zeiser, Andreas Burchert, Claudia Lengerke, Mareike Verbeek, Kristina Maas‐Bauer, Stephan Metzelder, Silvia Spoerl, Markus Ditschkowski, Matyas Ecsedi, Katja Sockel, Francis Ayuk, Salem Ajib, Flore Sicre de Fontbrune, Il‐Kang Na, Livius Penter, Udo Holtick, Dominik Wolf‎, Esther Schuler, Everett Meyer, Petya Apostolova, Hartmut Bertz, Reinhard Marks, Michael Lübbert, Ralph Wäsch, Christof Scheid, Friedrich Stölzel, Rainer Ordemann, Gesine Bug, Guido Kobbe, Robert S. Negrin, Mats Brune, Alexandros Spyridonidis, A Schmitt-Gräff, Walter J. F. M. van der Velden, Gerwin Huls, Stephan Mielke, Goetz Ulrich Grigoleit, Jürgen Kuball, Ryan Flynn, Gabriele Ihorst, Jing Du, Bruce R. Blazar, R. Arnold, Nicolaus Kröger, Jakob Passweg, Jörg Halter, G. Socié, Dietrich W. Beelen, Christian Peschel, Andreas Neubauer, Jürgen Finke, Justus Duyster, Nikolas von Bubnoff - Leukemia 2015 cited by 540

  6. Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation

    Authors: Loredana Ruggeri, Marusca Capanni, Myriam Casucci, Isabella Volpi, Antonellá Tosti, Katia Perruccio, Elena Urbani, Robert S. Negrin, Massimo F. Martelli, Andrea Velardi - Blood 1999 cited by 991

  7. Natural Killer Cells in Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation

    Authors: Federico Simonetta, Maite Álvarez, Robert S. Negrin - Frontiers in Immunology 2017 cited by 196

  8. T cells expressing chimeric antigen receptor promote immune tolerance

    Authors: Antonio Pierini, Bettina P. Iliopoulou, Heshan Peiris, Magdiel Pérez-Cruz, Jeanette Baker, Katie Hsu, Xueying Gu, Pingping Zheng, Tom Erkers, Sai-Wen Tang, W Strober, Maite Álvarez, Aaron M. Ring, Andrea Velardi, Robert S. Negrin, Seung K. Kim, Everett Meyer - JCI Insight 2017 cited by 105

  9. Incidence and risk factors associated with bleeding and thrombosis following chimeric antigen receptor T-cell therapy

    Authors: Andrew Johnsrud, Juliana Craig, John H. Baird, Jay Y. Spiegel, Lori Muffly, James L. Zehnder, John Tamaresis, Robert S. Negrin, Laura Johnston, Sally Arai, Judith A. Shizuru, Robert Lowsky, Everett Meyer, Wen‐Kai Weng, Parveen Shiraz, Andrew R. Rezvani, Theresa Latchford, Crystal L. Mackall, David B. Miklos, Matthew J. Frank, Surbhi Sidana - Blood Advances 2021 cited by 77

  10. Direct Imaging of Immune Rejection and Memory Induction by Allogeneic Mesenchymal Stromal Cells

    Authors: Lior Zangi, Raanan Margalit, Shlomit Reich-Zeliger, Esther Bachar-Lustig, Andreas Beilhack, Robert S. Negrin, Yaīr Reisner - Stem Cells 2009 cited by 292

  11. Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells

    Authors: Saar Gill, Adrianne E Vasey, Alysha De Souza, Jeanette Baker, Aaron T. Smith, Holbrook E. Kohrt, Mareike Florek, Kenneth D. Gibbs, Keri Tate, David S. Ritchie, Robert S. Negrin - Blood 2012 cited by 169

  12. Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming

    Authors: Federico Simonetta, Juliane K. Lohmeyer, Toshihito Hirai, Kristina Maas‐Bauer, Maite Álvarez, Arielle S. Wenokur, Jeanette Baker, Amin Aalipour, Xuhuai Ji, Samuel Haile, Crystal L. Mackall, Robert S. Negrin - Clinical Cancer Research 2021 cited by 56

  13. Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway

    Authors: Maite Álvarez, Federico Simonetta, Jeanette Baker, Antonio Pierini, Arielle S. Wenokur, Alyssa R. Morrison, William J. Murphy, Robert S. Negrin - JCI Insight 2019 cited by 94

  14. MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors

    Authors: Dominik Marschner, Martina Falk, Nóra Rebeka Jávorniczky, Kathrin Hanke-Müller, Justyna Rawluk, Annette Schmitt‐Graeff, Federico Simonetta, Eileen Haring, Severin Dicks, Manching Ku, Sandra Duquesne, Konrad Aumann, David Rafei‐Shamsabadi, Frank Meiß, Patrick S. Marschner, Melanie Boerries, Robert S. Negrin, Justus Duyster, Robert Zeiser, Natalie Köhler - JCI Insight 2020 cited by 87

  15. CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study

    Authors: Matthew J. Frank, John H. Baird, Anne Marijn Kramer, Hrishikesh K. Srinagesh, Shabnum Patel, Annie Kathleen Brown, Jean Oak, Sheren Younes, Yasodha Natkunam, Mark Hamilton, Yi‐Jiun Su, Neha Agarwal, Harshini Chinnasamy, Emily Egeler, Sharon Mavroukakis, Steven A. Feldman, Bita Sahaf, Crystal L. Mackall, Lori Muffly, David B. Miklos, Dorota D. Klysz, Nikolaos Gkitsas-Long, Juliana Bacigalupi, María Iglesias, Emma Crawford, Linnea Nichols, Kristen Cunanan, John Tamaresis, Jay Y. Spiegel, Zachary Ehlinger, Adam Kuo, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen Kai Weng, Sushma Bharadwaj, Saurabh Dahiya, Melody Smith, Liora M. Schultz, Sneha Ramakrishna, Kara L. Davis, Ramya Tunuguntla - The Lancet 2024 cited by 57

  16. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells

    Authors: Michael R. Verneris, Mobin Karami, Jeanette Baker, Anishka Jayaswal, Robert S. Negrin - Blood 2003 cited by 379

  17. CD22-directed CAR T-cell therapy induces complete remissions in CD19-directed CAR–refractory large B-cell lymphoma

    Authors: John H. Baird, Matthew J. Frank, Juliana Craig, Shabnum Patel, Jay Y. Spiegel, Bita Sahaf, Jean Oak, Sheren Younes, Michael G. Ozawa, Eric Yang, Yasodha Natkunam, John Tamaresis, Zachary Ehlinger, Warren D. Reynolds, Sally Arai, Laura Johnston, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, Parveen Shiraz, Surbhi Sidana, Wen‐Kai Weng, Kara L. Davis, Sneha Ramakrishna, Liora M. Schultz, Chelsea Mullins, Allison P. Jacob, Ilan Kirsch, Steven A. Feldman, Crystal L. Mackall, David B. Miklos, Lori Muffly - Blood 2020 cited by 80

  18. In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

    Authors: Ryosei Nishimura, Jeanette Baker, Andreas Beilhack, Robert Zeiser, Janelle A. Olson, Emanuela Sega, Mobin Karimi, Robert S. Negrin - Blood 2008 cited by 199

  19. A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant

    Authors: John A. Ronald, Byung-Su Kim, Gayatri Gowrishankar, Mohammad Namavari, Israt S. Alam, Aloma D’Souza, Hidekazu Nishikii, Hui-Yen Chuang, Ohad Ilovich, Chih-Feng Lin, Robert E. Reeves, Adam J. Shuhendler, Aileen Hoehne, Carmel T. Chan, Jeanette Baker, Shahriar Yaghoubi, Henry F. VanBrocklin, Randall A. Hawkins, Benjamin L. Franc, Salma Jivan, James B. Slater, Emily F. Verdin, Kenneth T. Gao, Jonathan Benjamin, Robert S. Negrin, Sanjiv S. Gambhir - Cancer Research 2017 cited by 133

  20. Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients

    Authors: Everett Meyer, Ginna G. Laport, Bryan J. Xie, Kate MacDonald, Kartoosh Heydari, Bita Sahaf, Sai-Wen Tang, Jeanette Baker, Randall Armstrong, Keri Tate, Cynthia Tadisco, Sally Arai, Laura Johnston, Robert Lowsky, Lori Muffly, Andrew R. Rezvani, Judith A. Shizuru, Wen‐Kai Weng, Kevin Sheehan, David B. Miklos, Robert S. Negrin - JCI Insight 2019 cited by 82

  21. Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and Recommendations

    Authors: Sergio Giralt, Luciano J. Costa, Jeffrey Schriber, John F. DiPersio, Richard T. Maziarz, John M. McCarty, Paul Shaughnessy, Edward L. Snyder, William Bensinger, Edward A. Copelan, Chitra Hosing, Robert S. Negrin, Finn Bo Petersen, Damiano Rondelli, Robert J. Soiffer, Helen Leather, Amy Pazzalia, Steven M. Devine - Biology of Blood and Marrow Transplantation 2013 cited by 404

  22. CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results

    Authors: Liora M. Schultz, Nikeshan Jeyakumar, Anne Marijn Kramer, Bita Sahaf, Hrishi Srinagesh, Parveen Shiraz, Neha Agarwal, Mark Hamilton, Courtney Erickson, Ashley Jacobs, Jennifer Moon, Christina Baggott, Sally Arai, Sushma Bharadwaj, Laura Johnston, Michaela Liedtke, Robert Lowsky, Everett Meyer, Robert S. Negrin, Andrew R. Rezvani, JUDY A. SHIZURU, Surbhi Sidana, Emily Egeler, Sharon Mavroukakis, Ramya Tunuguntla, Nikolaos Gkitsas-Long, Aidan Retherford, Annie Kathleen Brown, Anne-Louise Gramstrap-Petersen, Raquel Martin Ibañez, Steven A. Feldman, David B. Miklos, Crystal L. Mackall, Kara L. Davis, Matthew J. Frank, Sneha Ramakrishna, Lori Muffly - Leukemia 2024 cited by 40

  23. CAR19 monitoring by peripheral blood immunophenotyping reveals histology-specific expansion and toxicity

    Authors: Mark Hamilton, Erin Craig, Cesar Gentille Sanchez, Alain Mina, John Tamaresis, Nadia Kirmani, Zachary Ehlinger, Shriya Syal, Zinaida Good, Brian J. Sworder, Joseph G. Schroers‐Martin, Ying Lü, Lori Muffly, Robert S. Negrin, Sally Arai, Robert Lowsky, Everett Meyer, Andrew R. Rezvani, Judith A. Shizuru, Wen‐Kai Weng, Parveen Shiraz, Surbhi Sidana, Sushma Bharadwaj, Melody Smith, Saurabh Dahiya, Bita Sahaf, David M. Kurtz, Crystal L. Mackall, Robert Tibshirani, Ash A. Alizadeh, Matthew J. Frank, David B. Miklos - Blood Advances 2024 cited by 24

  24. Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

    Authors: Robert Zeiser, Vu Nguyen, Andreas Beilhack, Martin Buess, Stephan Schulz, Jeanette Baker, Christopher H. Contag, Robert S. Negrin - Blood 2006 cited by 498